A glutaminyl cyclase inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SEN-177

Item No. 40449

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
6′-fluoro-2-[4-(4-methyl-4H-1,2,4-triazol-3-yl)-1-piperidinyl]-3,3′-bipyridine
CAS Number
2117405-13-5
Molecular Formula
C18H19FN6
Formula Weight
338.4
Purity
≥98%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
Acetonitrile: SolubleDMSO: SolubleMethanol: Soluble
SMILES
FC1=NC=C(C2=C(N3CCC(CC3)C4=NN=CN4C)N=CC=C2)C=C1
InChi Code
InChI=1S/C18H19FN6/c1-24-12-22-23-17(24)13-6-9-25(10-7-13)18-15(3-2-8-20-18)14-4-5-16(19)21-11-14/h2-5,8,11-13H,6-7,9-10H2,1H3
InChi Key
AJIAMIPUWJQSPR-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    5 mg

    $54

    Add

    10 mg

    $103

    Add

    25 mg

    $244

    Add

    50 mg

    $432

    Add
    Product Description

    SEN-177 is a glutaminyl cyclase inhibitor (IC50 = 53 nM).1 It reduces polyglutamine aggregation in HeLa cells expressing EGFP-HTT-Q74, an in vitro model of Huntington’s disease when used at concentrations of 12.5 and 25 µM.2 SEN-177 (50 µM) reduces polyglutamine aggregation in primary mouse neurons expressing EGFP-Q80.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Park, E., Song, K.-H., Kim, D., et al. 2-Amino-1,3,4-thiadiazoles as glutaminyl cyclases inhibitors increase phagocytosis through modification of CD47-SIRPα checkpoint. ACS Med. Chem. Lett. 13(9), 1459-1467 (2022).

    2. Jimenez-Sanchez, M., Lam, W., Hannus, M., et al. siRNA screen identifies QPCT as a druggable target for Huntington’s disease. Nat. Chem. Biol. 11(5), 347-354 (2015).